Clinical Trials · NCT00003517
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Withdrawn
- Sponsor
- Burzynski Research Institute
- Enrollment
- 0
- Start date
- Not specified
- Locations
- 1 site, United States
- Primary endpoint
- Study in Adenocarcinoma of the Prostate